Literature DB >> 17219196

Inhaled nitric oxide increases endothelial permeability in Pseudomonas aeruginosa pneumonia.

Florence Ader1, Rozenn Le Berre, Steve Lancel, Karine Faure, Nathalie B Viget, Emmanuel Nowak, Rémi Nevière, Benoit P Guery.   

Abstract

OBJECTIVE: Pneumonia is a frequent cause of acute respiratory distress syndrome (ARDS), and Pseudomonas aeruginosa is a leading pathogen in nosocomial pneumonia. The management of ARDS remains a major problem, and only a limited number of options can improve the oxygenation. Inhaled nitric oxide (iNO) has been widely used, although this molecule is a free radical potentially harmful through the generation of toxic radical derivatives. The goal of our study was to assess the consequences of iNO (10 ppm) in a rat model of P. aeruginosa-induced lung injury.
DESIGN: The animals were exposed for 24 h to iNO after instillation of the pathogen. Distal alveolar fluid clearance (DAFC) and epithelial and endothelial permeability were measured with a double flux of radio-labeled albumin.
RESULTS: DAFC and epithelial permeability were increased in pneumonia but not influenced by iNO. In contrast, endothelial permeability was statistically significantly higher in the pneumonic animals exposed to iNO than in the pneumonic group without iNO (0.24+/-0.03 vs 0.47+/-0.1, p<0.05). This increase was not related to the production of nitrate/nitrite, nor to the increase of the inflammatory response evaluated by cytokine levels in the bronchoalveolar lavage fluid (TNF-alpha, IL-6, IL-10). The alveolar recruitment of polymorphonuclear neutrophils was comparable in the pneumonic group exposed to iNO and the pneumonic group without iNO.
CONCLUSION: iNO increases the endothelial permeability in P. aeruginosa pneumonia. The mechanism is not related to the production of nitrate/nitrite or to a greater inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219196     DOI: 10.1007/s00134-006-0497-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  40 in total

1.  Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression.

Authors:  Y Sato; K R Walley; M E Klut; D English; Y D'yachkova; J C Hogg; S F van Eeden
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

2.  Inhaled nitric oxide attenuates hyperoxic lung injury in lambs.

Authors:  Robert B Cotton; Håkan W Sundell; Darryl C Zeldin; Jason D Morrow; L Jackson Roberts; Tom A Hazinski; Amy B Law; Steven Steele
Journal:  Pediatr Res       Date:  2005-12-02       Impact factor: 3.756

Review 3.  Selective pulmonary vasodilation in acute respiratory distress syndrome.

Authors:  Udo Kaisers; Thilo Busch; Maria Deja; Bernd Donaubauer; Konrad J Falke
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  Nitric oxide attenuates lung endothelial injury caused by sublethal hyperoxia in rats.

Authors:  M C McElroy; J P Wiener-Kronish; H Miyazaki; T Sawa; K Modelska; L G Dobbs; J F Pittet
Journal:  Am J Physiol       Date:  1997-04

5.  Differential liquid and protein clearance from the alveoli of anesthetized sheep.

Authors:  M A Matthay; C C Landolt; N C Staub
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-07

6.  Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates.

Authors:  B Weinberger; L Fakhrzadeh; D E Heck; J D Laskin; C R Gardner; D L Laskin
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

7.  Effect of inhaled nitric oxide on key mediators of the inflammatory response in patients with acute lung injury.

Authors:  B H Cuthbertson; H F Galley; N R Webster
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

8.  An animal model of response and nonresponse to inhaled nitric oxide in endotoxin-induced lung injury.

Authors:  H Maurenbrecher; M Lamy; G Deby-Dupont; P Frascarolo; G Hedenstierna
Journal:  Chest       Date:  2001-08       Impact factor: 9.410

9.  Keratinocyte growth factor protects against Pseudomonas aeruginosa-induced lung injury.

Authors:  N B Viget; B P Guery; F Ader; R Nevière; S Alfandari; C Creuzy; M Roussel-Delvallez; C Foucher; C M Mason; G Beaucaire; J F Pittet
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

Review 10.  Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: a meta-analysis.

Authors:  Jennifer Sokol; Susan Elizabeth Jacobs; Desmond Bohn
Journal:  Anesth Analg       Date:  2003-10       Impact factor: 5.108

View more
  8 in total

1.  Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kγ) contributes to ventilator-induced lung injury and edema.

Authors:  Vito Fanelli; Valeria Puntorieri; Barbara Assenzio; Erica L Martin; Vincenzo Elia; Martino Bosco; Luisa Delsedime; Lorenzo Del Sorbo; Andrea Ferrari; Stefano Italiano; Alessandra Ghigo; Arthur S Slutsky; Emilio Hirsch; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2010-08-19       Impact factor: 17.440

2.  Stimulators of soluble guanylyl cyclase: future clinical indications.

Authors:  Bobby D Nossaman; Philip J Kadowitz
Journal:  Ochsner J       Date:  2013

3.  Endothelial nitric oxide synthase deficient mice are protected from lipopolysaccharide induced acute lung injury.

Authors:  Christine M Gross; Ruslan Rafikov; Sanjiv Kumar; Saurabh Aggarwal; P Benson Ham; Mary Louise Meadows; Mary Cherian-Shaw; Archana Kangath; Supriya Sridhar; Rudolf Lucas; Stephen M Black
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

4.  Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination.

Authors:  Stéphanie Bouillot; Patrick Munro; Benoit Gallet; Emeline Reboud; François Cretin; Guillaume Golovkine; Guy Schoehn; Ina Attrée; Emmanuel Lemichez; Philippe Huber
Journal:  Sci Rep       Date:  2017-05-18       Impact factor: 4.379

Review 5.  Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-04       Impact factor: 17.440

6.  Nitric oxide, leukocytes and microvascular permeability: causality or bystanders?

Authors:  Balázs Hauser; Martin Matejovic; Peter Radermacher
Journal:  Crit Care       Date:  2008-01-16       Impact factor: 9.097

Review 7.  Manipulation of acute inflammatory lung disease.

Authors:  E L Wissinger; J Saldana; A Didierlaurent; T Hussell
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

Review 8.  Dynamics of pulmonary endothelial barrier function in acute inflammation: mechanisms and therapeutic perspectives.

Authors:  Holger C Müller-Redetzky; Norbert Suttorp; Martin Witzenrath
Journal:  Cell Tissue Res       Date:  2014-03-06       Impact factor: 5.249

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.